BELLICUM PHARMACEUTICALS, INC reports

Company location: Houston, TX
Fiscal year end: 31 December

BELLICUM PHARMACEUTICALS, INC has filed 611 SEC EDGAR filings since 23 Mar 2006

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 51-75 of 606 matching filings.

Per page

25

Current page

3

10-K File 001-36783

10-K

Filing date: 31 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G/A File 005-88493

SC 13G/A filing

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88493

SC 13G/A

Filing date: 14 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-88493

SCHEDULE 13G/A

Filing date: 09 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A

Filing date: 20 Jan 2023
Reporting date: 03 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2023
Reporting date: 03 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2023
Reporting date: 03 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2023
Reporting date: 03 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2023
Reporting date: 03 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 05 Jan 2023
Reporting date: 03 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A

Filing date: 04 Jan 2023
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36783

8-K

Filing date: 12 Dec 2022
Reporting date: 08 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36783

8-K

Filing date: 07 Dec 2022
Reporting date: 05 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13D File 005-88493

SC 13D

Filing date: 18 Nov 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36783

8-K

Filing date: 10 Nov 2022
Reporting date: 10 Nov 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36783

10-Q

Filing date: 10 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

DEFA14A File 001-36783

DEFA14A

Filing date: 24 Oct 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

DEF 14A File 001-36783

DEF 14A

Filing date: 24 Oct 2022
Reporting date: 24 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

PRE 14A File 001-36783

PRE 14A

Filing date: 14 Oct 2022
Reporting date: 14 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Sep 2022
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Sep 2022
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Sep 2022
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Sep 2022
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Sep 2022
Reporting date: 01 Sep 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

FORM 4/A

Filing date: 01 Sep 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .